February 15, 2018 - ZOLL Showcases Systems of Care Products at EMS Today 2018


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637
[email protected]




February 15, 2018—CHELMSFORD, MASS.—ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, will offer EMS Today 2018 attendees the opportunity to experience the company’s portfolio of advanced CPR and acute critical care technologies, along with its integrated data solutions, in booth 904 on February 21-23 at the Charlotte Convention Center in North Carolina.

The products making up one-of-a-kind systems of care from ZOLL to be exhibited at EMS Today include:

Pediatric CPR on the X Series

ZOLL’s X Series® is the only monitor/defibrillator on the market that offers pediatric CPR feedback. Recent studies have determined that the quality of CPR in children is poor, with compressions frequently too shallow.1 While many providers are often hesitant to compress to the appropriate depth in pediatric cardiac arrest because they feel they might “hurt” the patient, ZOLL’s real-time pediatric CPR feedback arms providers with the information and confidence necessary to deliver high-quality CPR.

Resuscitation on the Move

Attendees will have the opportunity to experience moving patients in cardiac arrest using the AutoPulse® Resuscitation System. Participants will experience how quickly the AutoPulse can be deployed using the new Quick Case, which allows EMS providers to continue providing high-quality CPR while moving patients around tight corners and down steep stairs. Designed for Resuscitation on the Move™, a recent study showed that the AutoPulse had a significant survival benefit when compared to manual CPR when resuscitation efforts lasted longer than 16 minutes.2 In a meta-analysis of 12 comparative clinical trials, the AutoPulse improved the odds of return of spontaneous circulation (ROSC) by 62% when compared to manual CPR.3

ResQCPR System

Also on display will be the ResQCPR™ System, which utilizes active compression-decompression CPR (ACD-CPR) and an impedance threshold device (ITD) to improve blood flow to vital organs and increase the likelihood that patients will survive sudden cardiac arrest.4,5 The two-device combination was shown in a large clinical trial to improve survival to one year from out-of-hospital, non-traumatic cardiac arrest by 49% when compared to treatment with conventional cardiopulmonary resuscitation (CPR).5

Respiratory Care—Launching New Capabilities

With ZOLL’s EMV+® Ventilator, participants will have a unique experience by witnessing how a patient’s lungs adapt to different ventilator modes used in the pre-hospital environment. With ZOLL’s unique Smart HelpTM technology, the ZOLL ventilator provides on-screen prompts to guide users through alarm resolution. With a simple Touch, Turn & Confirm interface, a rugged design weighing just 9.7 lbs. and including a 10-hour battery, the ZOLL ventilator is designed to accommodate the specific needs of EMS.

ZOLL will also showcase new additional capabilities in the EMV+ that include inverse I:E ratio as well as plateau pressure measurement, allowing the EMS community to provide more tailored patient care for high-acuity patients such as those with acute respiratory distress syndrome (ARDS).

The RescueNet Journey

The ZOLL RescueNet® Experience shows attendees the journey of patient data from dispatch through discharge. When EMS software solutions are truly integrated, critical incident and patient data follow the patient from dispatch all the way through to post-event billing, saving EMS agencies both time and money. New is RescueNet BillingPro, which allows agencies to capture more revenue per claim, process clean claims faster, and focus on processes with the greatest return on investment.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corporation, with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.

11Niles, D, et al. Resuscitation. 2012 Mar;83(3):320–26.
22Olsen JA, et al. Acta Anaesthesiologica Scandinavica. 2015;60:222-229.
33Westfall M, et al. Crit Care Med. 2013 Jul;41(7):1782‐1789.
44Metzger A, et al. Crit Care Med. 2012;40(6):1851-1856.
55ResQCPR System Summary of Safety and Effectiveness Data approved by Food and Drug Administration 2015.

Copyright © 2018 ZOLL Medical Corporation. All rights reserved. AutoPulse, EMV+, RescueNet, ResQCPR, Resuscitation on the Move, Smart Help, X Series, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.